Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts
Background: Chagas disease is one of the leading causes of heart failure (HF) in Latin Americans, and there are limited data available that examine related costs of care for patients with HF. This study aimed to compare healthcare resource utilization and related costs for patients with HF, with and...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-07-01
|
| Series: | Therapeutic Advances in Infectious Disease |
| Online Access: | https://doi.org/10.1177/20499361221114270 |
| _version_ | 1811287518576902144 |
|---|---|
| author | Mario J. Olivera Adriana Arévalo Lyda Muñoz Sofía Duque Juan Bedoya Gabriel Parra-Henao |
| author_facet | Mario J. Olivera Adriana Arévalo Lyda Muñoz Sofía Duque Juan Bedoya Gabriel Parra-Henao |
| author_sort | Mario J. Olivera |
| collection | DOAJ |
| description | Background: Chagas disease is one of the leading causes of heart failure (HF) in Latin Americans, and there are limited data available that examine related costs of care for patients with HF. This study aimed to compare healthcare resource utilization and related costs for patients with HF, with and without Chagas disease. Methods: A prospective matched-cohort study comparing the healthcare costs for patients with HF with Chagas disease and care costs for patients with HF without Chagas disease was conducted between January 2019 and December 2019. Only direct costs have been estimated, including hospitalization costs, medications and other cardiovascular interventions, and clinical and laboratory follow-up for up to 1 year. Results: A total of 80 patients with chronic HF were included in the study. Of the 80 patients, 40 patients in the Chagas cohort and 40 patients in the non-Chagas cohort were matched for age, insurer and sex. From a social security system perspective, the total costs for the two cohorts during the study period were U$970,136. Specifically, the healthcare costs for the Chagas cohort were greater than the total healthcare costs for the non-Chagas group (U$511,931 versus U$458,205; p = 0.6183) Most costs were associated with hospitalizations (65.5% versus 59.6%), with averages of U$12,798.5 and U$11,455.1 per person in the Chagas and non-Chagas groups, respectively. In both the Chagas (51.6%) and non-Chagas cohorts (54.5%), causes of readmission unrelated to HF outweighed causes of readmission related to HF. High incidences of hospital admissions were observed during the rainy (cold) season for both cohorts Conclusions: Over a 12-month follow-up period, patients with chronic HF and Chagas consume as many healthcare resources as those with chronic HF and without Chagas. These data highlight the considerable and growing economic burden of HF on the Colombian health system. |
| first_indexed | 2024-04-13T03:20:02Z |
| format | Article |
| id | doaj.art-b8cce2b2eac6461997731a6c6b43bfd5 |
| institution | Directory Open Access Journal |
| issn | 2049-937X |
| language | English |
| last_indexed | 2024-04-13T03:20:02Z |
| publishDate | 2022-07-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Infectious Disease |
| spelling | doaj.art-b8cce2b2eac6461997731a6c6b43bfd52022-12-22T03:04:48ZengSAGE PublishingTherapeutic Advances in Infectious Disease2049-937X2022-07-01910.1177/20499361221114270Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohortsMario J. OliveraAdriana ArévaloLyda MuñozSofía DuqueJuan BedoyaGabriel Parra-HenaoBackground: Chagas disease is one of the leading causes of heart failure (HF) in Latin Americans, and there are limited data available that examine related costs of care for patients with HF. This study aimed to compare healthcare resource utilization and related costs for patients with HF, with and without Chagas disease. Methods: A prospective matched-cohort study comparing the healthcare costs for patients with HF with Chagas disease and care costs for patients with HF without Chagas disease was conducted between January 2019 and December 2019. Only direct costs have been estimated, including hospitalization costs, medications and other cardiovascular interventions, and clinical and laboratory follow-up for up to 1 year. Results: A total of 80 patients with chronic HF were included in the study. Of the 80 patients, 40 patients in the Chagas cohort and 40 patients in the non-Chagas cohort were matched for age, insurer and sex. From a social security system perspective, the total costs for the two cohorts during the study period were U$970,136. Specifically, the healthcare costs for the Chagas cohort were greater than the total healthcare costs for the non-Chagas group (U$511,931 versus U$458,205; p = 0.6183) Most costs were associated with hospitalizations (65.5% versus 59.6%), with averages of U$12,798.5 and U$11,455.1 per person in the Chagas and non-Chagas groups, respectively. In both the Chagas (51.6%) and non-Chagas cohorts (54.5%), causes of readmission unrelated to HF outweighed causes of readmission related to HF. High incidences of hospital admissions were observed during the rainy (cold) season for both cohorts Conclusions: Over a 12-month follow-up period, patients with chronic HF and Chagas consume as many healthcare resources as those with chronic HF and without Chagas. These data highlight the considerable and growing economic burden of HF on the Colombian health system.https://doi.org/10.1177/20499361221114270 |
| spellingShingle | Mario J. Olivera Adriana Arévalo Lyda Muñoz Sofía Duque Juan Bedoya Gabriel Parra-Henao Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts Therapeutic Advances in Infectious Disease |
| title | Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts |
| title_full | Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts |
| title_fullStr | Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts |
| title_full_unstemmed | Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts |
| title_short | Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts |
| title_sort | comparison of 1 year healthcare resource utilization and related costs for patients with heart failure in the chagas and non chagas matched cohorts |
| url | https://doi.org/10.1177/20499361221114270 |
| work_keys_str_mv | AT mariojolivera comparisonof1yearhealthcareresourceutilizationandrelatedcostsforpatientswithheartfailureinthechagasandnonchagasmatchedcohorts AT adrianaarevalo comparisonof1yearhealthcareresourceutilizationandrelatedcostsforpatientswithheartfailureinthechagasandnonchagasmatchedcohorts AT lydamunoz comparisonof1yearhealthcareresourceutilizationandrelatedcostsforpatientswithheartfailureinthechagasandnonchagasmatchedcohorts AT sofiaduque comparisonof1yearhealthcareresourceutilizationandrelatedcostsforpatientswithheartfailureinthechagasandnonchagasmatchedcohorts AT juanbedoya comparisonof1yearhealthcareresourceutilizationandrelatedcostsforpatientswithheartfailureinthechagasandnonchagasmatchedcohorts AT gabrielparrahenao comparisonof1yearhealthcareresourceutilizationandrelatedcostsforpatientswithheartfailureinthechagasandnonchagasmatchedcohorts |